GSK Investigational Site

Toronto, Ontario

Use our guide to learn which trials are right for you!

We've found
6 trials
at this facility
Scleroderma, Systemic Clinical Trial
Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Neoplasms Clinical Trial
Pilot Immunotherapy With Autologous T-cells Specific for New York Esophageal Antigen-1 (NY-ESO-1)/ Cancer-testis Antigen-2 (LAGE-1a)-Positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Cancer Clinical Trial
GSK3174998 Alone or With Pembrolizumab in Subjects With Advanced Solid Tumors (ENGAGE-1)
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Oncology Clinical Trial
Dose Escalation Study of GSK3326595 in Subjects With Solid Tumors and Non-Hodgkin's Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Neoplasms Clinical Trial
Phase II Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials